Stock PPCB PROPANC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Market Closed - OTC Markets
Other stock markets
 20:58:41 31/05/2024 BST 		5-day change 1st Jan Change
0.0019 USD -.--% Intraday chart for Propanc Biopharma, Inc. +72.73% -84.17%
05-15 Propanc Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
04-16 Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROPANC BIOPHARMA, INC. Stock Propanc Biopharma, Inc.
 319K - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. PPCB Stock
  4. Charts Propanc Biopharma, Inc.
  5. Sector Chart